Reduced cellular immunity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood:In Vitro studies of possible mechanisms

1986 ◽  
Vol 6 (6) ◽  
pp. 472-480 ◽  
Author(s):  
Roger H. Giller ◽  
Raleigh A. Bowden ◽  
Myron J. Levin ◽  
Lynn J. Walker ◽  
David G. Tubergen ◽  
...  
2005 ◽  
Vol 27 (10) ◽  
pp. 551-553 ◽  
Author(s):  
Elpis Mantadakis ◽  
Nicole Anagnostatou ◽  
Vassiliki Danilatou ◽  
Erasmia-Athina Markaki ◽  
Anna-Maria Spanaki ◽  
...  

2001 ◽  
Vol 37 (2) ◽  
pp. 145-147 ◽  
Author(s):  
Ingo Müller ◽  
Christian Aepinus ◽  
Robert Beck ◽  
Burkard Bültmann ◽  
Dietrich Niethammer ◽  
...  

2020 ◽  
Vol 92 (12) ◽  
pp. 3645-3649
Author(s):  
Joanna Zawitkowska ◽  
Monika Lejman ◽  
Anna Szmydki‐Baran ◽  
Agnieszka Zaucha‐Prażmo ◽  
Krzysztof Czyżewski ◽  
...  

Blood ◽  
1990 ◽  
Vol 75 (3) ◽  
pp. 806-809 ◽  
Author(s):  
S Kato ◽  
H Yabe ◽  
M Yabe ◽  
M Kimura ◽  
M Ito ◽  
...  

Abstract The transfer of antigen-specific cellular immunity in human bone marrow transplantation (BMT) was studied in 49 donor-recipient pairs, using a varicella-zoster-virus (VZV) specific lymphoproliferative response (LPR) assay. Posttransplant VZV-LPR could be serially measured in 31 long-term surviving recipients. VZV-specific T-cell immunity was detected in the early posttransplant period in 4 of 16 recipients who were, and whose donors were, immune to VZV before BMT, but two of those positive responses diminished in the first 100 days posttransplant. No positive response was detected in the immediate posttransplant period when either only the recipient or the donor was immune to VZV pretransplant. Herpes zoster or chickenpox developed in the recipients depending on a history of pretransplant VZV infection when the VZV-LPR became negative, and recovery from VZV infection was always followed by quick conversion of VZV-LPR. Long-lasting positive VZV-LPR was observed in the two recipients who experienced VZV infection in the immediate pretransplant period and received marrow graft from an immune donor. Our results indicate that a simple or direct transfer of VZV-specific cellular immunity from a marrow donor to a recipient cannot be expected in usual clinical bone marrow transplantation and that there might be a collaboration or recruitment of immune responses involving both donor and recipient that permits the VZV-LPR to remain positive posttransplant.


2014 ◽  
Vol 211 (4) ◽  
pp. 600-612 ◽  
Author(s):  
David Schub ◽  
Eva Janssen ◽  
Sarah Leyking ◽  
Urban Sester ◽  
Gunter Assmann ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document